Cannabis as Medicine: A Brief History of Humans Using a Plant While Pretending It’s Dangerous
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchPolicyCBDTHCPainAnxietyMental Health Why This Matters Clinicians need to understand that cannabinoid biology is…
Legislators Receive Medical Cannabis Update, Express Concerns | News
This medical cannabis legislative update highlights patient testimony on chronic pain management. Lawmakers express concerns about efficacy and safety in cannabis use. The evolving regulatory landscape impacts clinical recommendations and patient access.
The DEA’s cannabis hearings ask one question. The feds already answered it.
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchSafetyMental HealthPainAnxietyCBD Why This Matters Clinicians need to understand that federal…
Millions of New Yorkers consume cannabis; far fewer understand details, such as content …
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchSafetyDosingPolicyTHCCBDIndustry Why This Matters Clinicians need to understand that patient cannabis use may…
Harvard Researchers Detail CBD Nano-Micelle Protocol Designed to Improve Solubility and …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDSafetyDosingPolicyPainAnxiety Why This Matters Clinicians prescribing CBD or considering it for patients need…
Cannabis Formula Granted “Breakthrough Therapy Designation” by FDA for Pain Treatment
The FDA has granted breakthrough therapy designation to a cannabis breakthrough therapy pain treatment, signaling promise for standardized pain management. This designation may accelerate clinical development of cannabis-derived medications. Patients and…
France submits decree on the reimbursement of medical cannabis to the Council of State
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyPainNeurologyMental HealthSafetyResearchAnxiety Why This Matters France's reimbursement decision removes a…
Cannabis Terpenes Enhance THC’s Activation of Cannabinoid Receptors, Study Finds
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchTHCNeurologySafetyDosingMental HealthAnxiety Why This Matters Clinicians need to understand that cannabis…
HLB Life Science Selected for Fifth National Minor Cannabinoid Project
HLB Life Science has been selected for a fifth national project focused on minor cannabinoid drug development. This initiative highlights growing research into cannabinoid pharmaceuticals beyond THC and CBD. The project signals increasing institutional…
HLB Life Science R&D Launches Minor Cannabinoid Drug Development in Fifth State Project
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchHempIndustryPolicyCBDTHCNeurology Why This Matters Clinicians need to understand that minor cannabinoid drug…